| (S)-amphetamine | increases expression | EXP | | 6480464 | Dextroamphetamine results in increased expression of HNRNPH3 mRNA | CTD | PMID:12558987 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | decreases expression | ISO | RGD:1320680 | 6480464 | Metribolone results in decreased expression of HNRNPH3 protein | CTD | PMID:17152098 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1320680 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1320680 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1310019 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HNRNPH3 mRNA | CTD | PMID:21215274 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | EXP | | 6480464 | Oxazolone results in increased expression of HNRNPH3 mRNA | CTD | PMID:11379042 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of HNRNPH3 mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1320680 | 6480464 | [Tretinoin co-treated with Tamoxifen] results in decreased expression of HNRNPH3 protein | CTD | PMID:17098229 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1320680 | 6480464 | Tretinoin results in decreased expression of HNRNPH3 protein | CTD | PMID:17098229 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1320680 | 6480464 | Benzo(a)pyrene results in decreased expression of HNRNPH3 protein | CTD | PMID:20097212 |
| bisphenol A | decreases expression | ISO | RGD:1320680 | 6480464 | bisphenol A results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20678512 |
| copper atom | affects binding | ISO | RGD:1320680 | 6480464 | HNRNPH3 protein binds to Copper | CTD | PMID:15359738 |
| copper(0) | affects binding | ISO | RGD:1320680 | 6480464 | HNRNPH3 protein binds to Copper | CTD | PMID:15359738 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1320680 | 6480464 | Copper Sulfate results in decreased expression of HNRNPH3 mRNA | CTD | PMID:19549813 |
| coumestrol | increases expression | ISO | RGD:1320680 | 6480464 | Coumestrol results in increased expression of HNRNPH3 mRNA | CTD | PMID:19167446 |
| cyclosporin A | decreases expression | ISO | RGD:1320680 | 6480464 | Cyclosporine results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1320680 | 6480464 | Cyclosporine results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20106945 PMID:21632981 |
| diazoxide | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of HNRNPH3 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of HNRNPH3 mRNA | CTD | PMID:17361019 PMID:21266533 |
| diuron | decreases expression | ISO | RGD:1310019 | 6480464 | Diuron results in decreased expression of HNRNPH3 mRNA | CTD | PMID:21551480 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1320680 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of HNRNPH3 protein | CTD | PMID:18951874 |
| hydrogen peroxide | affects expression | ISO | RGD:1320680 | 6480464 | Hydrogen Peroxide affects the expression of HNRNPH3 mRNA | CTD | PMID:21179406 |
| isoprenaline | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20003209 |
| ketamine | decreases expression | ISO | RGD:1310019 | 6480464 | Ketamine results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20080153 |
| mercury atom | increases expression | ISO | RGD:1320680 | 6480464 | Mercury results in increased expression of HNRNPH3 mRNA | CTD | PMID:16823088 |
| mercury(0) | increases expression | ISO | RGD:1320680 | 6480464 | Mercury results in increased expression of HNRNPH3 mRNA | CTD | PMID:16823088 |
| nonanoic acid | decreases expression | EXP | | 6480464 | pelargonic acid results in decreased expression of HNRNPH3 mRNA | CTD | PMID:11379042 |
| paracetamol | decreases expression | ISO | RGD:1320680 | 6480464 | Acetaminophen results in decreased expression of HNRNPH3 mRNA | CTD | PMID:21420995 |
| quercetin | increases expression | ISO | RGD:1320680 | 6480464 | Quercetin results in increased expression of HNRNPH3 protein | CTD | PMID:17292933 |
| succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPH3 mRNA | CTD | PMID:21641980 |
| tamoxifen | decreases expression | ISO | RGD:1320680 | 6480464 | Tamoxifen results in decreased expression of HNRNPH3 protein | CTD | PMID:17098229 |
| tamoxifen | multiple interactions | ISO | RGD:1320680 | 6480464 | [Tretinoin co-treated with Tamoxifen] results in decreased expression of HNRNPH3 protein | CTD | PMID:17098229 |
| theophylline | multiple interactions | ISO | RGD:1320680 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of HNRNPH3 protein | CTD | PMID:18951874 |